The Motley Fool

Incyte Aktie (NASDAQ:INCY)

Incyte isn't the only drugmaker with a JAK inhibitor, but Jakafi's differentiation as a JAK1 and JAK2 inhibitor has helped the company stay on top of the treatment paradigm for myelofibrosis.

$65.47 $0.89 (0.01) Dienstag, 19. Oktober 2021 um 22:00:00 Mitteleuropäische Sommerzeit

About

Last updated 19-10-2021, 10:00:00pm CEST
Aktueller Kurs $65.47
Veränderung $0.89 (1.4%)
Schlusskurs $65.47
Eröffnung $64.69
Geld $65.00
Brief $65.70
Tagesspanne $64.57 - $65.69
52-Wochen-Spanne $64.08 - $101.47
Volumen 1,162,701
Durchschn. Volumen 1,547,808
Marktkapitalisierung $14,261,541,672.00
EPS (roll. Hochrechn.) $1.54

Related Articles